Medline announced today the acquisition of the Sensi-Care and Aloe Vesta collection of skin care product lines from ConvaTec, a global medical products and technologies company focused on therapies for the management of chronic conditions based in the U.K. The $29 million purchase brings the well-established brands of patient cleansing, moisturizing and skin protectants into Medline’s portfolio of advanced skin care products.
The sale is expected to close in the third quarter of 2020.
“We are really excited to bring Sensi-Care and Aloe Vesta into Medline’s Skin Care portfolio. Our holistic skin health solution has a particularly strong focus on preventative care with our skin care products at the core,” said Alyson Ovitt, vice president of Medline’s Skin Health division. “We have built a highly consultative approach that helps healthcare providers optimize product utilization while also delivering specialized product solutions for specific patient populations. The Sensi-Care and Aloe Vesta product lines are a perfect fit.”
Medline’s Skin Health portfolio and solutions help frontline staff reliably follow best practices in skin care. Medline Skin Health Solutions is built around three pillars:
- Best practice guidance
- Caregiver education
- System of products
The sale includes the Aloe Vesta and Sensi-Care skin care business in both the U.S. and Canada and gives Medline global rights to market outside North America.
For more information on Medline’s portfolio of advanced skin care products, visit Medline Skin Health’s Skin Care.